Parnell Pharmaceuticals Holdings Ltd to Present at Ladenburg Thalmann 2015 Healthcare Conference
September 28, 2015 13:54 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2015
August 11, 2015 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial stage pharmaceutical company focused on developing,...
Parnell Appoints Peter A. Croden to Board of Directors
August 10, 2015 14:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
Appointment increases Board to seven members, four of whom are independent
OVERLAND PARK, Kansas, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully...
Parnell to Report Financial Results for the Six Months Ended June 30, 2015 on August 11, 2015
July 29, 2015 16:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, July 29, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Investor Day Highlights
June 18, 2015 11:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, June 18, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces $11 Million Secured Term Loan Facility
June 18, 2015 07:30 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, June 18, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax(R), Disease-Modifying Osteoarthritis Drug in Dogs
June 18, 2015 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
– Detailed Zydax Trial Results to be Presented Today at Company Investor Day –
Meeting to be Webcast Beginning at 8:30 AM ET
OVERLAND PARK, Kansas, June 18, 2015 (GLOBE NEWSWIRE) --...
Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences
June 08, 2015 08:30 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., June 8, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Host Inaugural Investor Day on June 18, 2015
June 01, 2015 08:30 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., June 1, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Healthcare Conference
May 20, 2015 15:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., May 20, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...